Drreddys Laboratories | RDY - Net Income


Drreddys Laboratories reported INR12.1B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
ANI Pharmaceuticals USD 32.35M 6.08M Dec/2025
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Canopy Growth CAD -62.63M 60.99M Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Corcept Therapeutics USD 24.29M 4.62M Dec/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Novartis USD 2.41B 1.52B Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Richter Gedeon HUF 43.35B 8.49B Sep/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025